-E S Kleinerman Researcher Activity Profile

Research Author Detailed Information 

E S Kleinerman Publication Rate By Year

E S Kleinerman has published 1 paper(s) in 2006, 9 paper(s) in 2007, 5 paper(s) in 2008, for a total of 15 research publications in total.

E S Es Kleinerman Author Information

LAST NAME: kleinerman

FIRST NAME: E S

INITIALS: es

AFFILIATION:

Papers

E S Kleinerman's Publication Record

1. Intratumor murine interleukin-12 gene therapy suppressed the growth of local and distant Ewing's sarcoma. Year Published: 2006
Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
2. Corruption of the Fas pathway delays the pulmonary clearance of murine osteosarcoma cells, enhances their metastatic potential, and reduces the effect of aerosol gemcitabine. Year Published: 2007
Children's Cancer Hospital, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
3. Suppression of Ewing's sarcoma tumor growth, tumor vessel formation, and vasculogenesis following anti vascular endothelial growth factor receptor-2 therapy. Year Published: 2007
Division of Pediatrics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.
4. Fas-negative osteosarcoma tumor cells are selected during metastasis to the lungs: the role of the Fas pathway in the metastatic process of osteosarcoma. Year Published: 2007
Division of Pediatrics Research, Unit 853, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. nvkoshki@mdanderson.org
5. VEGF165, but not VEGF189, Stimulates Vasculogenesis and Bone Marrow Cell Migration into Ewing's Sarcoma Tumors In vivo. Year Published: 2007
Division of Pediatrics, The University of Texas M. D. Anderson Cancer Center, Unit 87, 1515 Holcombe Boulevard, Houston, TX 77030. ekleiner@mdanderson.org.
6. VEGF(165), but not VEGF(189), stimulates vasculogenesis and bone marrow cell migration into Ewing's sarcoma tumors in vivo. Year Published: 2007
Division of Pediatrics, The University of Texas M. D. Anderson Cancer Center, Unit 87, 1515 Holcombe Boulevard, Houston, TX 77030, USA.
7. Fas-negative osteosarcoma tumor cells are selected during metastasis to the lungs: the role of the Fas pathway in the metastatic process of osteosarcoma. Year Published: 2007
Division of Pediatrics Research, Unit 853, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. nvkoshki@mdanderson.org
8. Exploratory analysis of Fas gene polymorphisms in pediatric osteosarcoma patients. Year Published: 2007
Department of Pediatrics, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.
9. VEGF(165), but not VEGF(189), stimulates vasculogenesis and bone marrow cell migration into Ewing's sarcoma tumors in vivo. Year Published: 2007
Division of Pediatrics, The University of Texas M. D. Anderson Cancer Center, Unit 87, 1515 Holcombe Boulevard, Houston, TX 77030, USA.
10. Exploratory analysis of Fas gene polymorphisms in pediatric osteosarcoma patients. Year Published: 2007
Department of Pediatrics, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.
11. Intranasal granulocyte-macrophage colony-stimulating factor reduces the Aspergillus burden in an immunosuppressed murine model of pulmonary aspergillosis. Year Published: 2008
Department of Pediatrics, 1515 Holcombe Blvd., Box 87, Houston, TX 77030. ekleiner@mdanderson.org.
12. The Osterix Transcription Factor Down-Regulates Interleukin-1{alpha} Expression in Mouse Osteosarcoma Cells. Year Published: 2008
Division of Pediatrics, The University of Texas M. D. Anderson Cancer Center, Unit 87, 1515 Holcombe Boulevard, Houston, TX 77030. ekleiner@mdanderson.org.
13. Intranasal granulocyte-macrophage colony-stimulating factor reduces the Aspergillus burden in an immunosuppressed murine model of pulmonary aspergillosis. Year Published: 2008
The Children's Cancer Hospital, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, Texas 77030, USA.
14. The osterix transcription factor down-regulates interleukin-1 alpha expression in mouse osteosarcoma cells. Year Published: 2008
Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
15. The endogenous anti-angiogenic VEGF isoform, VEGF(165)b inhibits human tumour growth in mice. Year Published: 2008
1Microvascular Research Laboratories, Department of Physiology and Pharmacology, School of Veterinary Science, University of Bristol, Southwell Street, Bristol BS2 8EJ, UK.